there were better ways to target medicines precisely where they are needed? At Innocoll, our collagen-matrix technology is designed to transform today's medicines to help create a healthier tomorrow.
At Innocoll, our pipeline products are based on a proprietary collagen-matrix technology. In addition, we have filed a variety of key patents and patent applications for our products and technologies. Our collagen-based solutions are designed to address unmet needs in the areas of postsurgical pain management, diabetic foot infections and the prevention of surgical adhesions.
INL-001 (bupivacaine HCI collagen-matrix implants): In development for postsurgical analgesia
INL-002 (gentamicin collagen-matrix patch): In development for the treatment of diabetic foot infections
INL-003 (bioresorbable collagen film surgical adhesion barrier): In development for the prevention of surgical adhesions